Sesen Bio Operating Expenses 2011-2026 | SESN

Annual Operating Expenses Sesen Bio

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
81.8 M	104 M	66 M	35.1 M	32.3 M	36.9 M	25.7 M	20.6 M	28.2 M	36.2 M	35.2 M	17.8 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
104 M	17.8 M	43.3 M

Quarterly Operating Expenses Sesen Bio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.44 M	5.78 M	13.1 M	-	16.5 M	20.9 M	22.9 M	-	26.2 M	24.5 M	26.2 M	-	19.3 M	16.6 M	11 M	-	-63.1 M	27.6 M	59.5 M	-	32.7 M	26.4 M	-41.4 M	33.7 M	13.5 M	54.6 M	6.74 M	7.07 M	14.4 M	9.03 M	4.01 M	6.59 M	9.15 M	7.35 M	6.59 M	4.45 M	9.12 M	6.77 M	6.78 M	10.4 M	9.43 M	8.52 M	7.84 M	7.47 M	11.1 M	8.81 M	7.76 M	4.63 M	4.16 M	3.58 M	5.44 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
59.5 M	-63.1 M	11.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.89	-	$ 6.54 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.35	0.68 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	512 M	$ 103.69	2.08 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	63 M	$ 1.48	-0.67 %	$ 235 M	France
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.65	22.48 %	$ 6.01 M	Israel
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	85.5 M	$ 4.08	0.74 %	$ 436 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 22.65	1.25 %	$ 2.88 B	USA
Edesa Biotech EDSA	6.71 M	$ 16.23	2.08 %	$ 51.9 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.42	0.71 %	$ 378 M	Britain
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Evogene Ltd. EVGN	13.8 M	$ 0.79	4.79 %	$ 27.9 M	Israel
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Exelixis EXEL	598 M	$ 45.0	0.69 %	$ 12.2 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Завод ДИОД DIOD	249 M	-	-	-	Russia